FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W917151330> ?p ?o ?g. }

• W917151330 endingPage "155" @default.
• W917151330 startingPage "142" @default.
• W917151330 abstract "Chronic treatment with nicotine is known to increase the α4β2-nAChR sites in brain, to decrease α6β2-nAChR sites and to have minimal effect on α3β4-and α7-nAChR populations. Varenicline is now used as a smoking cessation treatment, with and without continued smoking or nicotine replacement therapy. Varenicline, like nicotine, upregulates the α4β2-nAChR sites; however, it is not known whether varenicline treatment changes expression of the other nAChR subtypes.Using a mouse model, chronic treatments (10 days) with varenicline (0.12 mg/kg/h) and/or nicotine (1 mg/kg/hr), alone or in combination, were compared for plasma and brain levels of drugs, tolerance to subsequent acute nicotine and expression of four subtypes of nAChR using autoradiography.The upregulation of α4β2-nAChR sites elicited by chronic varenicline was very similar to that elicited by chronic nicotine. Treatment with both drugs somewhat increased up-regulation, indicating that these doses were not quite at maximum effect. Similar down-regulation was seen for α6β2-nAChR sites. Varenicline significantly increased both α3β4-and α7-nAChR sites while nicotine had less effect on these sites. The drug combination was similar to varenicline alone for α3β4-nAChR sites, while for α7 sites the drug combination was less effective than varenicline alone. Varenicline had small but significant effects on tolerance to acute nicotine.Effects of varenicline in vivo may not be limited to the α4β2*-nAChR subtype. In addition, smoking cessation treatment with varenicline may not allow receptor numbers to be restored to baseline and may, in addition, change expression of other receptor subtypes." @default.
• W917151330 created "2016-06-24" @default.
• W917151330 creator A5008673262 @default.
• W917151330 creator A5014424133 @default.
• W917151330 creator A5020981498 @default.
• W917151330 creator A5048254436 @default.
• W917151330 creator A5080448364 @default.
• W917151330 creator A5080672470 @default.
• W917151330 creator A5085248648 @default.
• W917151330 creator A5086864255 @default.
• W917151330 creator A5090029775 @default.
• W917151330 date "2015-12-01" @default.
• W917151330 modified "2023-09-27" @default.
• W917151330 title "Chronic treatment with varenicline changes expression of four nAChR binding sites in mice" @default.
• W917151330 cites W1816201445 @default.
• W917151330 cites W1860200842 @default.
• W917151330 cites W1976416315 @default.
• W917151330 cites W1979212481 @default.
• W917151330 cites W1979580324 @default.
• W917151330 cites W1984698089 @default.
• W917151330 cites W1988865800 @default.
• W917151330 cites W1989152115 @default.
• W917151330 cites W1993112595 @default.
• W917151330 cites W1995989957 @default.
• W917151330 cites W1997910583 @default.
• W917151330 cites W2003949112 @default.
• W917151330 cites W2008410194 @default.
• W917151330 cites W2008808029 @default.
• W917151330 cites W2017703226 @default.
• W917151330 cites W2024566705 @default.
• W917151330 cites W2024620435 @default.
• W917151330 cites W2040525558 @default.
• W917151330 cites W2048403126 @default.
• W917151330 cites W2049774481 @default.
• W917151330 cites W2051618313 @default.
• W917151330 cites W2060450637 @default.
• W917151330 cites W2062040536 @default.
• W917151330 cites W2062197415 @default.
• W917151330 cites W2065671645 @default.
• W917151330 cites W2066273838 @default.
• W917151330 cites W2068493106 @default.
• W917151330 cites W2070269676 @default.
• W917151330 cites W2084289344 @default.
• W917151330 cites W2090507997 @default.
• W917151330 cites W2091374932 @default.
• W917151330 cites W2094580343 @default.
• W917151330 cites W2095601889 @default.
• W917151330 cites W2106076742 @default.
• W917151330 cites W2107774194 @default.
• W917151330 cites W2109720904 @default.
• W917151330 cites W2112940546 @default.
• W917151330 cites W2113934156 @default.
• W917151330 cites W2117452133 @default.
• W917151330 cites W2118793283 @default.
• W917151330 cites W2124166625 @default.
• W917151330 cites W2125937217 @default.
• W917151330 cites W2126739627 @default.
• W917151330 cites W2139654665 @default.
• W917151330 cites W2149679250 @default.
• W917151330 cites W2151020665 @default.
• W917151330 cites W2151079096 @default.
• W917151330 cites W2155400043 @default.
• W917151330 cites W2160083250 @default.
• W917151330 cites W2163138024 @default.
• W917151330 cites W2163171265 @default.
• W917151330 cites W2163574850 @default.
• W917151330 cites W2166251811 @default.
• W917151330 cites W2187317749 @default.
• W917151330 doi "https://doi.org/10.1016/j.neuropharm.2015.07.019" @default.
• W917151330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4655142" @default.
• W917151330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26192545" @default.
• W917151330 hasPublicationYear "2015" @default.
• W917151330 type Work @default.
• W917151330 sameAs 917151330 @default.
• W917151330 citedByCount "19" @default.
• W917151330 countsByYear W9171513302015 @default.
• W917151330 countsByYear W9171513302016 @default.
• W917151330 countsByYear W9171513302017 @default.
• W917151330 countsByYear W9171513302018 @default.
• W917151330 countsByYear W9171513302019 @default.
• W917151330 countsByYear W9171513302020 @default.
• W917151330 countsByYear W9171513302021 @default.
• W917151330 crossrefType "journal-article" @default.
• W917151330 hasAuthorship W917151330A5008673262 @default.
• W917151330 hasAuthorship W917151330A5014424133 @default.
• W917151330 hasAuthorship W917151330A5020981498 @default.
• W917151330 hasAuthorship W917151330A5048254436 @default.
• W917151330 hasAuthorship W917151330A5080448364 @default.
• W917151330 hasAuthorship W917151330A5080672470 @default.
• W917151330 hasAuthorship W917151330A5085248648 @default.
• W917151330 hasAuthorship W917151330A5086864255 @default.
• W917151330 hasAuthorship W917151330A5090029775 @default.
• W917151330 hasBestOaLocation W9171513302 @default.
• W917151330 hasConcept C126322002 @default.
• W917151330 hasConcept C142724271 @default.
• W917151330 hasConcept C170493617 @default.
• W917151330 hasConcept C188987157 @default.
• W917151330 hasConcept C2777053506 @default.

• next